Cargando…

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect

Clonality analysis of immunoglobulin (IG) or T-cell receptor (TR) gene rearrangements is routine practice to assist diagnosis of lymphoid malignancies. Participation in external quality assessment (EQA) aids laboratories in identifying systematic shortcomings. The aim of this study was to evaluate l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keppens, Cleo, Boone, Elke, Gameiro, Paula, Tack, Véronique, Moreau, Elisabeth, Hodges, Elizabeth, Evans, Paul, Brüggemann, Monika, Carter, Ian, Lenze, Dido, Sarasquete, Maria Eugenia, Möbs, Markus, Liu, Hongxiang, Dequeker, Elisabeth M. C., Groenen, Patricia J. T. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364525/ https://www.ncbi.nlm.nih.gov/pubmed/33686511 http://dx.doi.org/10.1007/s00428-021-03046-0

Ejemplares similares

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
por: Keppens, Cleo, et al.
Publicado: (2020)

Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
por: Keppens, Cleo, et al.
Publicado: (2020)

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey
por: Deans, Zandra C., et al.
Publicado: (2017)

A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality Consortium
por: Armand, Marine, et al.
Publicado: (2019)

Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories
por: Tack, Véronique, et al.
Publicado: (2018)

Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
por: Keppens, Cleo, et al.
Publicado: (2019)

Interpretation of EQA results and EQA-based trouble shooting
por: Kristensen, Gunn Berit Berge, et al.
Publicado: (2017)

PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation
por: Keppens, Cleo, et al.
Publicado: (2020)

Demystifying EQA statistics and reports
por: Coucke, Wim, et al.
Publicado: (2017)

A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer
por: Keppens, Cleo, et al.
Publicado: (2018)

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016–2018
por: Donoso Mantke, Oliver, et al.
Publicado: (2018)

Inter-Laboratory Comparisons and EQA in the Mediterranean Area
por: Haliassos, Alexander
Publicado: (2018)

The challenge of producing an EQA for the COVID-19 pandemic
por: Badrick, Tony, et al.
Publicado: (2020)

European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects
por: Keppens, Cleo, et al.
Publicado: (2019)

The role of EQA in harmonization in laboratory medicine – a global effort
por: Jones, Graham R.D.
Publicado: (2017)

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
por: Langerak, A W, et al.
Publicado: (2012)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
por: Patton, S, et al.
Publicado: (2014)

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
por: Deans, Zandra C., et al.
Publicado: (2019)

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS
por: Scheijen, Blanca, et al.
Publicado: (2019)

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme
por: Manser, Monika, et al.
Publicado: (2013)

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
por: Akpa, Chidimma Agatha, et al.
Publicado: (2019)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

Polymerase Chain Reaction-Based Clonality Analysis of Cutaneous B-Cell Lymphoproliferative Processes
por: Melotti, Claudia Z, et al.
Publicado: (2010)

District level external quality assurance (EQA) of malaria microscopy in Pakistan: pilot implementation and feasibility
por: Khan, Muhammad Amir, et al.
Publicado: (2011)

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
por: Emile, Jean-François, et al.
Publicado: (2013)

Standardization in laboratory medicine: Two years’ experience from category 1 EQA programs in Spain
por: Ricós, Carmen, et al.
Publicado: (2018)

Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment
por: De la Salle, Barbara
Publicado: (2017)

External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany
por: Selb, Regina, et al.
Publicado: (2020)

EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing
por: Tong, Qing, et al.
Publicado: (2021)

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021)

Indolent CD56-Positive Clonal T-Cell Lymphoproliferative Disease of the Stomach Mimicking Lymphomatoid Gastropathy
por: Hong, Mineui, et al.
Publicado: (2014)

Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples
por: Keppens, Cleo, et al.
Publicado: (2020)

The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmes
por: Boeras, Debrah I., et al.
Publicado: (2016)

Comprehensive clinical evaluation of TomoEQA for patient-specific pre-treatment quality assurance in helical tomotherapy
por: Kim, Changhwan, et al.
Publicado: (2022)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
por: Fairley, Jennifer A., et al.
Publicado: (2022)

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay
por: Kim, Young, et al.
Publicado: (2013)

Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders
por: Granai, Massimo, et al.
Publicado: (2021)

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
por: Vollbrecht, Claudia, et al.
Publicado: (2018)

Evaluation of a collaborative model for successful implementation of a National CD4 enumeration EQA program in Cameroon
por: Sagnia, Bertrand, et al.
Publicado: (2021)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o4ajpgiveblopnv4ieg6ruoom0